Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Croma Australia is the regional subsidiary of Croma-Pharma, a global leader in the production of hyaluronic acid syringes and minimally invasive aesthetic medicine. The company offers a comprehensive portfolio that includes the Saypha range of hyaluronic acid fillers, PDO lifting threads, and the botulinum toxin Letybo. Croma Australia focuses on providing high-quality medical devices and skincare products to healthcare professionals in the dermatology and plastic surgery sectors. Their operations are backed by the parent company's advanced manufacturing facility in Austria, which is one of the most modern in the world. The company is dedicated to advancing the field of aesthetics through education and the distribution of scientifically proven rejuvenation treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CROMA Australia.